RCKT

Rocket Pharmaceuticals, Inc. Common Stock
Data: 2026-01-30
$3.48
Price
-2.39%
Change
$11.45
52W High
$2.19
52W Low

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

Quick Stats
Jan 30, 2026

53.1

AI Score

HOLD

0.86

Volume Ratio

Feb 26, 2026

Next Earnings

11

+ve Days (30d)

17

-ve Days (30d)

RCKT Stock Summary

Last updated Jan 30, 2026

RCKT is currently trading at $3.48, positioned below its 200-day moving average of $3.77, suggesting bearish momentum. The stock has a 52-week range of $2.19 to $11.45.

Technical Analysis: The 50-day moving average stands at $3.45, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 44.634, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.023, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates RCKT at 53.1/100 with a HOLD recommendation.

RCKT (Rocket Pharmaceuticals, Inc. Common Stock) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 44.634
CMF (20) -0.023
ROC (10) -6.199
ADX (14) 25.712
Indicator Value
MACD (12,26,9) 0.02
AROONOSC (14) -100.0
WILLAMS %R (14) -78.125
MFI (14) 45.01
RCKT Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

RCKT Price vs Max Options Open Interest
RCKT Max Change In Options Open Interest

RCKT Options - Sort by Max open Interest (near term)

30th January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

RCKT Daily Out of Money Options - Sort by Max open Interest (near term)

30th January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

RCKT Daily In the Money Options - Sort by Max open Interest (near term)

30th January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

RCKT Most Active Options by Volume(near term)

30th January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Rocket Pharmaceuticals, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

RCKT Moving Averages Analysis

Rocket Pharmaceuticals, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026

RCKT (Rocket Pharmaceuticals, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 3.63
20 3.67
30 3.59
50 3.45
100 3.44
200 3.77

RCKT Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 387.4 million
Earnings/Share ($) -2.25
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -2.0195
EPS Estimate Next Year ($) -1.2464
WallStreet Target Price ($) 7.65
Most Recent Quarter